Skip to content

A Study on the Efficacy of High-intensity Laser Therapy in the Treatment of Acute Low Back Pain

A Study on the Efficacy of High-intensity Laser Therapy in the Treatment of Acute Low Back Pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101189
Enrollment
Unknown
Registered
2025-04-21
Start date
2025-04-24
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute low back pain

Interventions

High-intensity Laser Group:High-energy laser therapy + Etoricoxib Tablets (60 mg per day) + Eperisone Hydrochloride Tablets (1 tablet, three times a day)
Sham Laser Group:Sham therapy + Etoricoxib Tablets (60 mg per day) + Eperisone Hydrochloride Tablets (1 tablet, three times a day)

Sponsors

The First Affiliated Hospital of Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The age is >= 18 years old; 2. Meeting the diagnostic criteria for "acute low back pain" in the "Evidence-Based Clinical Practice Guidelines for Low Back Pain" of the North American Spine Society (NASS), that is, the onset time of low back pain is within 6 weeks; 3. The Visual Analogue Scale (VAS) score for pain intensity is >= 40 points;

Exclusion criteria

Exclusion criteria: 1. Organic diseases such as lumbar fracture, tumor, tuberculosis, etc.; 2. Complicated with severe diseases of important organs such as heart, liver, kidney, etc.; 3. Pregnant or lactating women; 4. Patients with contraindications to laser treatment; 5. Patients who have received other treatments for low back pain within the past month, such as surgery, physical therapy, steroid injection, etc.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale (VAS) score;

Secondary

MeasureTime frame
Oswestry Disability Index (ODI);SF-36;The time (number of times) when the pain significantly subsides (the Visual Analogue Scale (VAS) score decreases by >= 20 points or more than 50% after the treatment is completed);;Situation of Isokinetic Muscle Strength Assessment;The occurrence of adverse events and serious adverse events during the treatment period, as well as the total amount of oral medications.;

Countries

China

Contacts

Public ContactGu Nan

The First Affiliated Hospital of Air Force Medical University

gunn818@126.com+86 139 9129 2113

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026